Nuclear magnetic resonance-based metabolomics identifies phenylalanine as a novel predictor of incident heart failure hospitalisation: results from PROSPER and FINRISK 1997.
Delles C, Rankin NJ, Boachie C, McConnachie A, Ford I, Kangas A, Soininen P, Trompet S, Mooijaart SP, Jukema JW, Zannad F, Ala-Korpela M, Salomaa V, Havulinna AS, Welsh P, Würtz P, Sattar N.
Delles C, et al.
Eur J Heart Fail. 2018 Apr;20(4):663-673. doi: 10.1002/ejhf.1076. Epub 2017 Dec 11.
Eur J Heart Fail. 2018.
PMID: 29226610
Free PMC article.
Clinical Trial.